Justin J. File is CFO at Evofem Biosciences, Inc. (EVFM). They have made 5 open-market trades across 1 company since 2019, most recently 2022-02-18.
CIK 0001726277
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $84K since 2020, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EVFM | 810,982 | $388K |
Shares reported on the most recent Form 4, priced at the 2022-02-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVFM | BUY | 2021-12-20 | 2021-12-20 | $0.37 | $15K | -9.0% | +18.2% | -5.4% |
| EVFM | BUY | 2021-06-10 | 2021-06-10 | $1.03 | $25K | +1.8% | -14.6% | -26.6% |
| EVFM | BUY | 2020-11-17 | 2020-11-18 | $2.17 | $17K | -6.5% | -9.1% | +72.8% |
| EVFM | BUY | 2020-06-12 | 2020-06-15 | $3.14 | $27K | -1.0% | -4.5% | -23.9% |
| EVFM | SELL · 10b5-1 | 2020-01-13 | 2020-01-15 | $6.00 | $10K | -14.8% | -8.1% | -12.0% |
| EVFM | SELL · 10b5-1 | 2020-01-02 | 2020-01-06 | $6.05 | $20K | +10.2% | -15.7% | -10.0% |
| EVFM | SELL | 2019-12-02 | 2019-12-04 | $7.16 | $72K | -10.8% | -14.0% | -7.7% |
| EVFM | SELL · 10b5-1 | 2019-11-20 | 2019-11-21 | $6.00 | $30K | +3.1% | -2.8% | +6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.